Adamis Pharmaceuticals Corp.

... ...
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.03%36.490.9%$1154.32m
JNJJohnson & Johnson -0.37%161.780.7%$1117.52m
LLYEli Lilly & Co. 0.49%202.251.1%$869.09m
ABBVAbbVie, Inc. -1.21%111.261.9%$725.93m
MRKMerck & Co., Inc. -1.58%81.160.7%$665.58m
BMYBristol-Myers Squibb Co. -3.11%64.191.0%$665.40m
AZNAstraZeneca Plc 0.59%52.551.2%$655.25m
ARCTArcturus Therapeutics Holdings, Inc. -5.25%63.770.0%$218.22m
VTRSViatris, Inc. -2.15%17.310.0%$192.75m
GRTSGritstone Oncology, Inc. 0.24%25.550.0%$192.12m
RPRXRoyalty Pharma Plc 0.14%50.420.2%$171.44m
NVSNovartis AG -0.03%96.890.2%$165.88m
GSKGlaxoSmithKline Plc -0.63%37.780.2%$146.68m
SNYSanofi -0.54%49.640.2%$128.45m
RGENRepligen Corp. 0.11%216.916.9%$81.68m

Company Profile

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.